The Lankenau Institute for Medical Research (EIN: 23-2175659) is dedicated to advancing human health and well-being through innovative research in technology and health. With an operating budget of $19.9 million and total revenue of $10.7 million for the 2024 filing year, the organization focuses on improving disease detection and treatment, transferring new technologies to clinical settings, and training the next generation of scientists and physicians. The institute does not rely on any single funder for 50% or more of its revenue, ensuring a diverse funding base to support its mission. For more information, visit www.limr.org.